- Report
- December 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- November 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- October 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- September 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- December 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- September 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- March 2026
- 140 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- February 2026
- 185 Pages
Global
From €4383EUR$4,950USD£3,756GBP
- Report
- February 2026
- 101 Pages
Global
From €3055EUR$3,450USD£2,618GBP
- Report
- October 2025
- 85 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- September 2025
- 140 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- August 2025
- 109 Pages
Global
From €3055EUR$3,450USD£2,618GBP
- Report
- August 2025
- 197 Pages
Global
From €4383EUR$4,950USD£3,756GBP
- Report
- September 2025
- 247 Pages
United States
From €1638EUR$1,850USD£1,404GBP
- Report
- February 2026
- 94 Pages
Europe
From €3498EUR$3,950USD£2,997GBP
- Report
- February 2026
- 90 Pages
Asia Pacific
From €3498EUR$3,950USD£2,997GBP
- Report
- February 2026
- 76 Pages
Middle East, Africa
From €3055EUR$3,450USD£2,618GBP
- Report
- February 2026
- 84 Pages
North America
From €3055EUR$3,450USD£2,618GBP
- Report
- August 2025
- 73 Pages
Africa, Middle East
From €3055EUR$3,450USD£2,618GBP
- Report
- August 2025
- 97 Pages
Asia Pacific
From €3498EUR$3,950USD£2,997GBP

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more